IP Library Granted Patent US 8,776,786
Granted Patent B2
US 8,776,786 · App. 13/423,044 · Granted Jul 15, 2014

Pulse drug nebulization system, formulations therefore, and methods of use

Inventors: Edward R Kraft (Galveston, TX); Perenlai Enkhbaatar (Galveston, TX); Daniel S Traber (Galveston, TX); Gabriela A. Kulp (Santa Fe, TX)
Assignee: The Regents of the University of Texas System
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,776,786
App. No.
13/423,044
Granted
Jul 15, 2014
Kind
B2
Abstract

Liquid nebulizer apparatus, systems, and formulation compositions, as well as systems for the nebulized, aerosol delivery of such compositions, for the administration and insufflation of medicinal aerosols into the pulmonary system of a mammal are described. The nebulizing apparatus and system can effectively aerosolize a variety of viscosities of medicinal liquid drug carriers, including those made up of oil, water, or emulsions of oil and water. Drugs dissolved or suspended in the compositions and formulations described and adapted for use herein are not damaged or denatured by the nebulization process when the nebulizer described is used. Further, the nebulization system itself can be adapted for use with both mechanically assisted pulmonary ventilation systems as well as hand-held inhalers and nose/mouth face masks for use in pulmonary drug delivery.

Claims (29)

1. A pulmonary drug delivery system capable of nebulizing a drug composition comprising a water-insoluble or substantially water-insoluble drug and a fatty acid or lipid, the system comprising:

a carrier gas reservoir;

a drug reservoir comprising a flexible bladder that is disposed within the carrier gas reservoir and that is able to be pressurized by gas within the carrier gas reservoir;

a face mask; and

a nebulizing nozzle in fluid communication with face mask, the drug reservoir and the carrier gas reservoir, wherein the nebulizing nozzle comprises an outer carrier gas delivery tube spaced apart from and disposed around at least one inner drug delivery tube and wherein the outer carrier gas delivery tube and the at least one inner drug delivery tube(s) share a longitudinal axis and are together dimensioned and disposed such that expulsion of a carrier gas through the outer carrier gas delivery tube forms an outer surrounding stream of carrier gas that carries an inner flow of fluid from the drug reservoir in a center of carrier gas flow exiting the nebulizing nozzle and thereby produces aerosol drug containing droplets having a particle size ranging from about 2 μm to about 12 μm in median mass aerodynamic size that are delivered to a patient via a mouth and/or nose of the patient.

2. The pulmonary drug delivery system of claim 1 , further comprising a mechanical ventilator.

3. The pulmonary drug delivery system of claim 2 , wherein the mechanical ventilator is configured to synchronize a cyclic nebulization of the aerosol drug containing droplets.

4. The pulmonary drug delivery system of claim 1 , wherein the nebulizing nozzle can produce aerosol drug containing droplets having a particle size ranging from about 2 μm to about 5 μm.

5. The pulmonary drug delivery system of claim 1 , wherein the nozzle has an air volume to nebulized droplet volume ratio less than about 60,000:1.

6. The pulmonary drug delivery system of claim 5 , wherein the nozzle has an air volume to nebulized droplet volume ratio less than about 15,000:1.

7. The pulmonary drug delivery system of claim 1 , wherein an intermediate air space between the outer carrier gas delivery tube and the inner drug delivery tube ranges from about 0.000009 in 2 to about 0.001 in 2 .

8. The pulmonary drug delivery system of claim 7 , wherein an intermediate air space between the outer carrier gas delivery tube and the inner drug delivery tube ranges from about 0.00000259 in 2 to about 0.001 in 2 .

9. The pulmonary drug delivery system of claim 1 , wherein the outer carrier gas delivery tube has an inner diameter ranging from about 0.01 inches to about 0.05 inches.

10. The pulmonary drug delivery system of claim 1 , wherein the outer gas delivery tube is disposed around a plurality of individual inner drug delivery tubes disposed within, and sharing a longitudinal axis with, the outer gas delivery tube.

11. The pulmonary drug delivery system of claim 10 , wherein the plurality of individual drug delivery tubes ranges from 2 to 12 individual drug delivery tubes disposed within the outer gas delivery tube.

12. The pulmonary drug delivery system of claim 10 , where the relative dimensions of the outer gas delivery tube and the plurality of individual inner drug delivery tubes produce the aerosol drug containing droplets having a particle size ranging from about 2 μm to about 12 μm in median mass aerodynamic size.

13. A pulmonary drug delivery system capable of nebulizing a drug composition comprising a water-insoluble or substantially water-insoluble drug and a fatty acid or lipid, the system comprising:

a drug reservoir;

a carrier gas reservoir;

a face mask; and

a nebulizing nozzle in fluid communication with face mask, the drug reservoir and the carrier gas reservoir, wherein the nebulizing nozzle comprises an outer carrier gas delivery tube spaced apart from and disposed around at least one inner drug delivery tube and wherein the outer carrier gas delivery tube and the at least one inner drug delivery tube(s) share a longitudinal axis and are together dimensioned and disposed such that expulsion of a carrier gas through the outer carrier gas delivery tube forms an outer surrounding stream of carrier gas that carries an inner flow of fluid from the drug reservoir in a center of carrier gas flow exiting the nebulizing nozzle and thereby produces aerosol drug containing droplets having a particle size ranging from about 2 μm to about 12 μm in median mass aerodynamic size that are delivered to a patient via a mouth and/or nose of the patient, wherein the drug reservoir is disposed within a pressurization chamber that is adapted to force delivery of a drug from the drug reservoir into the drug delivery tube and wherein the pressurization chamber can be pressurized by the carrier gas reservoir.

14. The pulmonary drug delivery system of claim 13 , further comprising a spring loaded flow valve positioned and adapted to control pressurization by the carrier gas reservoir.

15. The pulmonary drug delivery system of claim 13 , further comprising a spring loaded blow-off valve positioned and adapted to prevent excess pressure in the pressurization chamber.

16. A pulmonary drug delivery system capable of nebulizing a drug composition comprising a water-insoluble or substantially water-insoluble drug and a fatty acid or lipid, the system comprising:

a nebulizing nozzle in fluid communication with a drug reservoir that is disposed within a carrier gas reservoir, wherein the drug reservoir is adapted to be pressurized by gas within the carrier gas reservoir and thereby force delivery of a drug from the drug reservoir into the nebulizing nozzle, and

wherein the nebulizing nozzle comprises an outer carrier gas delivery tube spaced apart from and disposed around at least one inner drug delivery tube and wherein the outer carrier gas delivery tube and the at least one inner drug delivery tube(s) share a longitudinal axis and are together dimensioned and disposed such that expulsion of a carrier gas through the outer carrier gas delivery tube forms an outer surrounding stream of carrier gas that carries an inner flow of fluid from the drug reservoir in a center of carrier gas flow exiting the nebulizing nozzle and thereby produces aerosol drug containing droplets having a particle size ranging from about 2 μm to about 12 μm in median mass aerodynamic size.

17. The pulmonary drug delivery system of claim 16 , wherein the drug reservoir is a flexible bladder that is disposed within the carrier gas reservoir.

18. The pulmonary drug delivery system of claim 16 , further comprising a spring loaded flow valve positioned and adapted to control pressurization by the carrier gas reservoir.

19. The pulmonary drug delivery system of claim 16 , further comprising a spring loaded blow-off valve positioned and adapted to prevent excess pressure in the pressurization chamber.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 22, 2017
From: UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042941/0460 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2013
From: KRAFT, EDWARD R.; ENKHBAATAR, PERENLEI; TRABER, DANIEL L.; KULP, GABRIELA A.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 031016/0884 →
Continuity (4)
Division 11855870 · Sep 14, 2007
Provisional Application 60845087 · Sep 15, 2006
Provisional Application 60891128 · Feb 22, 2007
Related Publication 20120174915A1 · Jul 12, 2012